Literature DB >> 10467345

Novel aspects of Ras proteins biology: regulation and implications.

D Pérez-Sala1, A Rebollo.   

Abstract

The importance of Ras proteins as crucial crossroads in cellular signaling pathways has been well established. In spite of the elucidation of the mechanism of RAS activation by growth factors and the delineation of MAP kinase cascades, the overall framework of Ras interactions is far from being complete. Novel regulators of Ras GDP/GTP exchange have been identified that may mediate the activation of Ras in response to changes in intracellular calcium and diacylglycerol. The direct activation of Ras by free radicals such as nitric oxide also suggests potential regulation of Ras function by the cellular redox state. In addition, the array of Ras effectors continues to expand, uncovering links between Ras and other cellular signaling pathways. Ras is emerging as a dual regulator of cellular functions, playing either positive or negative roles in the regulation of proliferation and apoptosis. The signals transmitted by Ras may be modulated by other pathways triggered in parallel, resulting in the final order for proliferation or apoptosis. The diversity of ras-mediated effects may be related in part to differential involvement of Ras homologues in distinct cellular processes. The study of Ras posttranslational modifications has yielded a broad battery of inhibitors that have been envisaged as anti-cancer agents. Although an irreversible modification, Ras isoprenylation appears to be modulated by growth factors and by the activity of the isoprenoid biosynthetic pathway, which may lead to changes in Ras activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467345     DOI: 10.1038/sj.cdd.4400557

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  8 in total

1.  The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.

Authors:  Jose Luis Oliva; Dolores Pérez-Sala; Antonio Castrillo; Natalia Martínez; F Javier Cañada; Lisardo Boscá; José M Rojas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

Review 2.  Signaling molecules and pathways regulating the fate of spermatogonial stem cells.

Authors:  Zuping He; Maria Kokkinaki; Martin Dym
Journal:  Microsc Res Tech       Date:  2009-08       Impact factor: 2.769

3.  Translocation of ethanolamine phosphoglyceride is required for initiation of apoptotic death in OLN-93 oligodendroglial cells.

Authors:  Annette Brand; Ephraim Yavin
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

4.  Gdnf upregulates c-Fos transcription via the Ras/Erk1/2 pathway to promote mouse spermatogonial stem cell proliferation.

Authors:  Zuping He; Jiji Jiang; Maria Kokkinaki; Nady Golestaneh; Marie-Claude Hofmann; Martin Dym
Journal:  Stem Cells       Date:  2007-10-25       Impact factor: 6.277

5.  Inflammatory cytokines promote inducible nitric oxide synthase-mediated DNA damage in hamster gallbladder epithelial cells.

Authors:  Amane Kitasato; Yoshitsugu Tajima; Tamotsu Kuroki; Ryuji Tsutsumi; Tomohiko Adachi; Takehiro Mishima; Takashi Kanematsu
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

6.  Hydrogen peroxide toxicity induces Ras signaling in human neuroblastoma SH-SY5Y cultured cells.

Authors:  Jirapa Chetsawang; Piyarat Govitrapong; Banthit Chetsawang
Journal:  J Biomed Biotechnol       Date:  2010-09-05

7.  The C-terminus of H-Ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways.

Authors:  Clara L Oeste; Beatriz Díez-Dacal; Francesca Bray; Mario García de Lacoba; Beatriz G de la Torre; David Andreu; Antonio J Ruiz-Sánchez; Ezequiel Pérez-Inestrosa; Carlota A García-Domínguez; José M Rojas; Dolores Pérez-Sala
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

8.  The C-terminal sequence of RhoB directs protein degradation through an endo-lysosomal pathway.

Authors:  Dolores Pérez-Sala; Patricia Boya; Irene Ramos; Mónica Herrera; Konstantinos Stamatakis
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.